Eli Lilly and Co say the US government has bought 614,000 additional doses of its Covid-19 antibody therapy for $1.29 billion, reports Reuters.

Under the deal, Lilly will supply a minimum of 400,000 doses of its treatment by December 31 and the rest by January 31.